New Jersey Dangerous Drug Lawyers

When an over-the-counter product needs closer review

It is easy to assume that a medicine sold without a prescription, shelved a few feet from vitamins and toothpaste, must be safe. Non-prescription drugs are real medicines with real dosing limits, and people are injured every year by products they bought for a headache, a cold, joint pain, or trouble sleeping – sometimes while following the label, and sometimes after a professional told them the product was fine for them.

A review of harm from an over-the-counter drug usually runs on two tracks, and separating them early matters because they lead to different defendants and different proof. Our New Jersey medical malpractice overview explains the professional-negligence side of that analysis.

• The product track: Was this drug unreasonably dangerous as sold, or did its labeling fail to warn adequately about a risk that materialized?
• The advice track: Did a doctor, pharmacist, or other provider recommend or endorse this product for a patient whose prescriptions, conditions, or age made it a poor and foreseeable risky choice?
• The personal risk factors: Liver or kidney disease, alcohol use, pregnancy, older age, and existing prescriptions can all change whether an ordinary over-the-counter drug is safe for a particular person.

Neither track is established by the injury alone; each requires its own evidence.

How over-the-counter drugs cause serious harm

The dangers of non-prescription medicines are well documented and, in hindsight, often look obvious: the same active ingredient hiding in several products at once, a warning printed for a healthy adult being applied to someone it does not fit, or a familiar drug quietly conflicting with a prescription.

Acetaminophen and liver injury

Acetaminophen appears in pain relievers, cold and flu remedies, and sleep aids, so a person treating several symptoms can exceed the maximum daily amount without ever taking an extra dose of any single product. The total from every source, over every day of use, is what a review must reconstruct.

NSAIDs, bleeding, and kidney harm

Ibuprofen, naproxen, and aspirin reduce pain and inflammation, but they can damage the stomach lining, contribute to gastrointestinal bleeding, strain the kidneys, and raise blood pressure. The risks climb for older patients, for people who are dehydrated or have kidney disease, and for anyone also taking a blood thinner.

Interactions with prescription medicines

Over-the-counter products do not arrive in an empty body. When a pharmacist recommends a product without checking the prescription profile on file, or a provider suggests one without reviewing the patient’s medication list, the interaction that follows is not simply bad luck; it is a foreseeable result of advice given without the patient’s full picture.

Inadequate warnings and recalled products

Some claims concern the warnings themselves: directions or cautions that do not adequately communicate a known risk to the people actually using the product,. Federal recalls and safety warnings can also identify products, lots, or risks after injuries have occurred. A recall does not decide an individual case, but it can be significant evidence about the product.

Where the problem is instead a mistake with a prescribed medicine – the wrong drug ordered, filled, or administered – the analysis differs, and our page on pharmaceutical and prescription drug errors covers that ground.

Preserving the product evidence and getting answers

Seek medical care first, and tell the treating clinicians the exact name of every product you have been taking, prescription and non-prescription alike. Do not take more of a product you believe has harmed you while you wait for answers.

• Keep the product and its packaging. Retain the bottle or box, the inserts, and the dosing device, and note the lot number and expiration date. Do not throw the packaging away and do not finish the remaining product; both can matter later.
• Save proof of purchase. Receipts, pharmacy loyalty records, and online order confirmations help establish which product, made by whom and in which batch, you actually used, and when.
• Photograph the label and directions. Images preserve what the packaging said at the time, which matters if labeling later changes.
• Write down who advised you. If a pharmacist, doctor, or clinic recommended the product, record who it was, where, and what was said, including whether anyone asked about your other medications.
• Build the dose timeline. Note what you took, how much, how often, and for how long, together with your other medicines and the date symptoms began. Hospital records, liver or kidney test results, and any endoscopy or bleeding workup belong in the same file.

Adverse events can also be reported to the FDA, and federal recall information is worth checking while it is available. Your own packaging, receipts, and medical records are what connect the product to your injury.

What New Jersey requires in a dangerous drug case

The first legal task in one of these cases is classification, because an over-the-counter injury can proceed on either of two distinct theories, and sometimes on both. A claim aimed at the product itself is a product liability claim, directed at the manufacturer or seller and concerned with whether the drug was defective or its warnings inadequate. A claim aimed at the advice is a malpractice claim, judged by whether the professional who recommended the product met the standard of care for a patient with this history and these prescriptions.

Personal injury claims in New Jersey are generally subject to the two-year period in N.J.S.A. 2A:14-2. Because liver or kidney damage may build gradually and the connection to a familiar product may not be apparent at first, when the claim accrued and how the discovery rule applies deserve prompt, specific analysis.

The Affidavit of Merit requirement illustrates why classification matters. Where the case alleges malpractice by a licensed professional, such as a physician or pharmacist who recommended the product, N.J.S.A. 2A:53A-27 requires a sworn statement from a qualified professional that there is a reasonable probability the advice departed from acceptable standards, served within 60 days after that defendant answers, with one further 60-day period possible for good cause. A claim framed purely against a manufacturer follows a different proof path, so a mixed case must manage both tracks at once.

Under comparative negligence, N.J.S.A. 2A:15-5.1, a defendant may argue that the injured person used the product contrary to its label directions or continued taking it after symptoms appeared, and recovery is barred if the plaintiff’s share of fault is greater than the defendants’. New Jersey does not cap compensatory damages in medical malpractice cases. One exception applies: claims against nonprofit hospitals are capped at $250,000 under the charitable immunity statute, N.J.S.A. 2A:53A-8. If the recommendation came from a public clinic or another public entity, a Tort Claims Act notice within 90 days under N.J.S.A. 59:8-8 may also be required.

Documenting the full impact of a dangerous drug injury

Liver failure, a bleeding ulcer, or kidney damage can require intensive treatment and leave a person with permanent restrictions, and the losses a claim addresses should reflect that full course rather than the first emergency visit.

• Treatment costs: Hospitalization, specialist care, procedures to stop internal bleeding, treatment for liver or kidney injury, and the medication changes the injury forces, all supported by records and bills.
• Future care and monitoring: Ongoing laboratory testing, specialist follow-up, dietary or medication restrictions, and any further treatment a supported prognosis shows will reasonably be required.
• Work and income: Time lost during treatment and recovery, and any enduring effect on the ability to work, documented through employment and wage records.
• Pain, suffering, and daily life: The physical effects of the injury together with disability, impairment, and the loss of activities and independence the person previously had.
• Losses to the family: Where a dangerous product causes a death, surviving family members may have claims under New Jersey’s wrongful death framework, which follows separate rules and deadlines.

Keep the bills, test results, wage records, and treatment recommendations as they arrive, and keep your own record of how the injury has changed ordinary life. Documentation assembled early, while packaging and purchase records are still available, is what these claims rest on.

Why consider The Epstein Law Firm for a dangerous drug claim?

A dangerous drug case may require a lawyer to separate a product-and-warnings claim from a professional-advice claim, organize medical and product records into a clear chronology, and work with appropriately qualified experts. The Epstein Law Firm’s published attorney biographies identify experience and professional qualifications relevant to that work.

Civil trial certification and medical malpractice experience

Barry D. Epstein’s biography lists medical malpractice among his practice areas and identifies his certification by the Supreme Court of New Jersey as a Civil Trial Attorney beginning in 1984. Michael J. Epstein’s biography also lists medical malpractice and Civil Trial Attorney certification. Those are civil-trial credentials; they are not medical qualifications or a guarantee that a particular claim will succeed.

Teaching, writing, and professional leadership

Barry Epstein’s biography documents two 1990 Institute for Continuing Legal Education presentations titled “How to Try a Medical Malpractice Case” and service as a Tort Law Conference moderator and speaker from 2006 through 2018. It also records his New Jersey State Bar Association presidency in 2000–2001.

Michael Epstein’s biography identifies his authorship of the Bergen County Bar Association’s monthly Civil Practice Update and his service as that association’s president in 2016–2017. At a consultation, ask who will evaluate the records, how expert qualifications will be checked, and how the evidence would be developed.

Recognition in context

Barry Epstein’s biography lists selection to the Top 100 New Jersey Super Lawyers list for 2005–2016, 2018, and 2020. These are historical selections attributed to the individual attorney, not a dangerous-drug-case success rate. No aspect of this advertisement has been approved by the Supreme Court of New Jersey. Results depend on the facts and law applicable to each case.

Sources: The Epstein Law Firm: Barry D. Epstein biography; The Epstein Law Firm: Michael J. Epstein biography; The Epstein Law Firm: Rating methodology.

The firm offers a free initial consultation. Its Rochelle Park office is at 340 West Passaic Street, Rochelle Park NJ 07662. Call (201) 231-7847 to discuss what happened, the injury, and whether further review is appropriate.

Sources: The Epstein Law Firm: Contact and office information; The Epstein Law Firm: Medical malpractice representation.

What Our Clients Say

Meet The Epstein Law Firm

Related medical malpractice topics

• Medical Malpractice
• Surgery Malpractice
• Misdiagnosis
• Hospital Errors
• Emergency Room Errors
• Delayed Diagnosis of Disease
• Dangerous Over the Counter Drugs
• Birth Injury Overview
• Anesthesia Errors
• Sexual Assaults in Hospitals

New Jersey Dangerous Drug FAQs: Over-the-Counter Products, Warnings, and Claims

These answers provide general information about New Jersey claims involving dangerous over-the-counter drugs, including product, warning, and professional-advice theories. They are not legal advice or an assessment of an individual case.

Can an over-the-counter drug really support a dangerous drug claim in New Jersey?

Yes. Non-prescription status describes how a product is sold, not whether it can cause serious injury or whether its warnings were adequate. A claim may rest on the product being unreasonably dangerous, on labeling that failed to warn about a risk, or on a professional recommending that product to a patient for whom it was unsafe.

Each of those theories has different defendants and different proof, so the review starts with the product itself, the dose and duration of use, the medical outcome, what the label said, and who, if anyone, advised using it. An injury by itself establishes none of them.

Sources: FDA drug safety information; New Jersey Courts civil division

What is the difference between a defective drug claim and a malpractice claim in New Jersey?

The focus differs. A defective drug, or product liability, claim examines the product: how it was made, what risks it carried, and whether its warnings adequately told users about them, and it is directed at the manufacturer or seller. A malpractice claim examines a professional’s judgment for an individual patient.

A single injury can involve both, for example where a product carried an understated warning and a pharmacist steered a high-risk patient toward it anyway. The distinction matters in practice because the malpractice track carries additional requirements, including expert support and the affidavit of merit, that the product track does not.

Sources: New Jersey Courts civil division; FDA drug safety information

Can a pharmacist be responsible for recommending an unsafe over-the-counter drug?

A pharmacist who counsels a patient is expected to use what the pharmacy knows about that patient, including prescriptions on file, recorded allergies, and known conditions, and to warn when an over-the-counter product could interact with them or aggravate a condition. Steering a patient to a product without that check, or reassuring them despite a visible interaction risk, can be called into question.

Proof turns on what the pharmacist could see in the profile, what was actually said at the counter, and what the store’s records show. Write your recollection down promptly, note anyone who was with you, and keep the receipt and packaging.

Sources: FDA drug safety information; AHRQ medication safety resources

What if a doctor told me to take an over-the-counter drug that interacted with my prescription?

That can support a malpractice claim. A provider who recommends a non-prescription product is expected to consider the medications and conditions the patient already has, and advising a product that foreseeably interacts with an existing prescription may fall below the standard of care. Qualified expert testimony is ordinarily needed to explain both.

The visit records from that recommendation, the written instructions you were given, and the medication list as it stood at the time are central evidence, so request and preserve them. If you are having symptoms now, seek medical attention promptly and describe every product you take.

Sources: AHRQ medication safety resources; FDA drug safety information

How can acetaminophen in over-the-counter products harm the liver?

Acetaminophen is processed by the liver, and taking more than the maximum daily amount can injure that organ, occasionally severely. The trap is that the ingredient appears in many separate products for pain, fever, colds, flu, and sleep, so a person treating several symptoms at once can exceed the limit without ever overusing any one product.

A review therefore totals the acetaminophen from every source across each day of use and compares that picture with liver test results and the timing of symptoms, taking alcohol use and existing liver conditions into account. Saving every package allows that total to be reconstructed accurately.

Sources: FDA drug safety information; NJ DOBI consumer information

What should I save after an over-the-counter drug makes me sick?

Save the product itself, its box or bottle, the printed inserts, and the lot and expiration numbers, and keep the purchase receipt or online order confirmation. Photograph the front panel, the active ingredient list, and the warnings as they appear on your package. Do not use up the remaining product.

Add a written timeline of the doses you took, the other medicines you were using, when symptoms began, and the treatment you received, together with any record of who recommended the product. Packaging and lot information can connect a specific unit to a recall or a production batch, and purchase records fix dates that memory blurs.

Sources: FDA drug safety information; New Jersey Courts civil division

Does an FDA recall mean I automatically have a case in New Jersey?

No. A recall or an FDA safety warning is important, and it may show that a risk associated with a product became recognized, but an individual claim still requires proof that the product caused this person’s injury and that a defendant is legally responsible under the theory being pursued.

The absence of a recall does not end the inquiry either, because warnings can be inadequate for a product that remains on the market. Preserve the product and its lot information, compare them with the recall’s terms, and check the applicable filing deadlines, which continue to run while the public picture develops.

Sources: FDA drug safety information; New Jersey Courts civil division

How long do I have to file a dangerous drug claim in New Jersey?

Generally two years, under the personal injury statute at N.J.S.A. 2A:14-2, measured from when the claim accrues. Dangerous drug cases raise real questions about that starting point, because liver or kidney injury may develop gradually and the link to a familiar store-bought product may not be apparent when symptoms first appear, which is where the discovery rule can become relevant.

Those questions are decided on particular facts, and gradual injury should never be treated as an open-ended extension. If the product was recommended by a public clinic or another public entity, a Tort Claims Act notice within 90 days may also be required.

Sources: NJ two-year filing statute; NJ Tort Claims Act notice

Is an affidavit of merit required for every dangerous drug case in New Jersey?

Not necessarily. The Affidavit of Merit statute, N.J.S.A. 2A:53A-27, applies to claims alleging malpractice by a licensed professional, and it requires a qualified professional’s sworn statement that there is a reasonable probability the professional’s conduct fell outside acceptable standards. A claim aimed solely at a manufacturer over a defective product or inadequate warnings follows a different proof path.

In a mixed case, the affidavit is then due generally within 60 days after that defendant answers, with one additional 60-day period possible for good cause. Classifying the claims correctly at the outset is what prevents that deadline from being missed.

Sources: NJ affidavit of merit statute; New Jersey Courts civil division

What compensation may be available after a dangerous over-the-counter drug injury?

A supported claim may include the cost of treating the injury, including hospitalization, specialist care, and the monitoring the injury makes necessary, along with future care, lost earnings, and compensation for pain, suffering, disability, and the loss of ordinary activities. New Jersey does not cap compensatory damages in medical malpractice cases, though every category of loss still has to be documented and proved. One exception applies: claims against nonprofit hospitals are capped at $250,000 under the charitable immunity statute, N.J.S.A. 2A:53A-8.

If the product caused a death, surviving family members may pursue losses under New Jersey’s wrongful death statute, which has its own procedures. Keep bills, test results, wage records, and treatment recommendations, and note the help you now need with everyday tasks.

Sources: NJ DOBI consumer information; NJ wrongful death statute; New Jersey Courts civil division

Related Epstein Law Firm Videos and Social Posts

• Medical Malpractice — YouTube.
• The Epstein Law Firm official Instagram profile — official profile.
• Medical Malpractice Settlement Recognition — Facebook.
• Medical Malpractice and Personal Injury Recognition — Facebook.
• The Firm’s 2026 Best Law Firms Recognition — LinkedIn.